Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Did they really say that?

This article was originally published in Clinica

Executive Summary

The quotes tell the story. During the last year, many key players in the industry spoke their minds over issues such as the CE mark, user fees, device reuse and FDA reform. Clinica looks back at some of the most controversial and succinct observations.The CE mark for devices "seems only to mean that the person that plugs it in will not get an electric shock". A remark few in the device industry would agree with but it more than exemplified the debate in Europe over the value of the CE mark which continued throughout 1999. It came from Professor Martin Buxton, director of the health economics research group at London's Brunel University, at a meeting on the UK's new National Institute of Clinical Excellence.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel